Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models
X. Li, P. Lidsky, Y. Xiao, C.-T. Wu, M. Garcia-Knight, J. Yang, T. Nakayama, J. V. Nayak, P. K. Jackson, R. Andino, X. Shu
This study identifies ethacridine, an FDA-approved antiseptic, as a potent inhibitor of SARS-CoV-2 by inactivating viral particles in cellular models.
bioRxiv · Oct 28, 2020Microbiology